Emilia Bagiella, PhD
img_Emilia Bagiella
PROFESSOR | Population Health Science and Policy

Laurea, Universita' degli studi

MS, Columbia University

PhD, Columbia University


Selected Publications

A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19. Michael E. Bowdish, Christina E. Barkauskas, Jessica R. Overbey, Robert L. Gottlieb, Keren Osman, Abhijit Duggal, Mary E. Marks, Jonathan Hupf, Eustace Fernandes, Bradley G. Leshnower, Jonathan L. Golob, Alexander Iribarne, Athos J. Rassias, Ellen G. Moquete, Karen O'Sullivan, Helena L. Chang, Judson B. Williams, Sam Parnia, Nirav C. Patel, Nimesh D. Desai, Andrew M. Vekstein, Beth A. Hollister, Tammie Possemato, Christian Romero, Peter C. Hou, Elizabeth Burke, Jack Hayes, Fred Grossman, Silviu Itescu, Marc Gillinov, Francis D. Pagani, Patrick T. O'Gara, Michael J. Mack, Peter K. Smith, Emilia Bagiella, Alan J. Moskowitz, Annetine C. Gelijns. American Journal of Respiratory and Critical Care Medicine

Pacemaker implantation associated with tricuspid repair in the setting of mitral valve surgery: Insights from a Cardiothoracic Surgical Trials Network randomized trial. Gorav Ailawadi, Pierre Voisine, Samantha Raymond, Annetine C. Gelijns, Alan J. Moskowitz, Volkmar Falk, Jessica R. Overbey, Michael W.A. Chu, Michael J. Mack, Michael E. Bowdish, Markus Krane, Babatunde Yerokun, Lenard Conradi, Steven F. Bolling, Marissa A. Miller, Wendy C. Taddei-Peters, Kathleen N. Fenton, Neal O. Jeffries, Robert S. Kramer, Arnar Geirsson, Ellen G. Moquete, Karen O'Sullivan, Jonathan Hupf, Judy Hung, Friedhelm Beyersdorf, Emilia Bagiella, James S. Gammie, Patrick T. O'Gara, Alexander Iribarne, Michael A. Borger, Marc Gillinov. Journal of Thoracic and Cardiovascular Surgery

Integrating non-concurrent controls in the analyses of late-entry experimental arms in multi-arm trials with a shared control group in the presence of parameter drift. Jessica R. Overbey, Ying Kuen Cheung, Emilia Bagiella. Contemporary Clinical Trials

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Bagiella during 2022 and/or 2023. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Other activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • Pharmaceutical Research Associates (PRA)
  • Albert Einstein

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.